T2 Biosystems, Inc. (TTOO)

OTCMKTS · Delayed Price · Currency is USD
0.0030
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
-97.65%
Market Cap 84.14K
Revenue (ttm) 7.68M
Net Income (ttm) -42.95M
Shares Out 28.05M
EPS (ttm) -4.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35
Average Volume 12,245
Open 0.0115
Previous Close 0.0030
Day's Range 0.0030 - 0.0115
52-Week Range 0.0001 - 0.1800
Beta 0.88
RSI 62.63
Earnings Date Feb 13, 2026

About T2 Biosystems

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts. [Read more]

Sector Healthcare
Founded 2006
Employees 113
Stock Exchange OTCMKTS
Ticker Symbol TTOO
Full Company Profile

Financial Performance

In 2023, T2 Biosystems's revenue was $7.19 million, a decrease of -67.75% compared to the previous year's $22.31 million. Losses were -$50.08 million, -19.66% less than in 2022.

Financial Statements

News

There is no news available yet.